The MYOVANCE brand, founded in 2005 (United States), from 7 sister brands and 2214 competing brands. The MYOVANCE brand is owned by Amicus Therapeutics, a company listed in New York. MYOVANCE belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Amicus Therapeutics
(MYOVANCE)
over 5 years*
USD 7.71